Fortress Biotech (FBIO) Current Leases: 2019-2025
Historic Current Leases for Fortress Biotech (FBIO) over the last 7 years, with Sep 2025 value amounting to $2.1 million.
- Fortress Biotech's Current Leases fell 15.31% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 15.31%. This contributed to the annual value of $2.6 million for FY2024, which is 3.96% up from last year.
- Latest data reveals that Fortress Biotech reported Current Leases of $2.1 million as of Q3 2025, which was down 0.51% from $2.1 million recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's Current Leases peaked at $2.6 million during Q4 2024, and registered a low of $1.8 million during Q1 2021.
- In the last 3 years, Fortress Biotech's Current Leases had a median value of $2.5 million in 2024 and averaged $2.4 million.
- As far as peak fluctuations go, Fortress Biotech's Current Leases climbed by 20.62% in 2021, and later declined by 16.99% in 2025.
- Quarterly analysis of 5 years shows Fortress Biotech's Current Leases stood at $2.1 million in 2021, then grew by 16.30% to $2.4 million in 2022, then increased by 3.11% to $2.5 million in 2023, then climbed by 3.96% to $2.6 million in 2024, then dropped by 15.31% to $2.1 million in 2025.
- Its Current Leases was $2.1 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.2 million in Q1 2025.